Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $173.40 | Total: $867.00 |
| 1 | 10 | $146.88 | Total: $1,468.80 |
| 1 | 25 | $124.44 | Total: $3,111.00 |
| 1 | 50 | $106.08 | Total: $5,304.00 |
| 1 | 100 | $91.80 | Total: $9,180.00 |
Overview
PF-03635659 is a potent and long dissociative half-life muscarinic M3 antagonist (Ki: 0.2 nM) that shows potential for the treatment of chronic obstructive pulmonary disease (COPD).
Chemical Properties
| Molecular Formula | C28H32N2O3 |
| Molecular Weight | 444.57 |
| CAS Numbers | 931409-24-4 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | C(CCC(C)(C)N1CC(OC2=CC(O)=CC=C2)C1)(C(N)=O)(C3=CC=CC=C3)C4=CC=CC=C4 |
Storage and Handling
0C Short Term, -20C Long Term
References
Glossop PA, et al. Inhalation by design novel tertiary amine muscarinic M? receptor antagonists with slow off-rate binding kinetics for inhaled once-daily treatment of chronic obstructive pulmonary disease. J Med Chem. 2011;54[19] 6888-6904.